Skip to main content

Table 2 Histologic Characteristics of biopsies included in this study

From: Diagnostic performance of glomerular PLA2R and THSD7A antibodies in biopsy confirmed primary membranous nephropathy in South Africans

 

PMN

(n = 41)

LN-V

(n = 19)

DN

(n = 28)

p-value

Total

Number of glomeruli per view (n [IQR])

15 (10–21)

16 (8–20)

16 (10–26)

0.47

15 (10–23)

Sclerosed glomeruli (n)

0.0 (0.0-6.7)

0.0 (0.0-2.6)

22.5 (8.4–48.7)

0.001

0.0 (0.0-14.8)

Tubular atrophy [n (%)]

7 (17.1)

4 (21.1)

18 (64.3)

< 0.001

29 (32.9)

Interstitial fibrosis [n (%)]

12 (29.3)

7 (36.8)

26 (92.9)

< 0.001

45 (51.1)

Immunohistochemistry:

 • IgG [n (%)]

31 (75.6)

16 (84.2)

4 (14.3)

< 0.001

51 (57.9)

 • IgA [n (%)]

9 (21.9)

7 (36.8)

1 (3.6)

0.02

17 (19.3)

 • IgM [n (%)]

16 (39.0)

13 (68.4)

8 (28.6)

0.02

37 (42.1)

 • C3 [n (%)]

31 (75.6)

10 (52.6)

7 (25.0)

< 0.001

48 (54.5)

PLA2R (positive)

21 (51.2)

0 (0.0)

0 (0.0)

< 0.001

21 (23.9)

THSD7A (positive)

2 (4.9)

0 (0.0)

0 (0.0)

0.31

2 (2.3)

  1. PMN Primary membranous nephropathy, LN-V class V lupus nephritis, DN diabetic nephropathy, IQR Interquartile range; IgA Immunoglobulin A, IgG Immunoglobulin G, IgM Immunoglobulin G, C3 Complement factor 3; PLA2R phospholipase A-2 receptor; THSD7A thrombospondin type-1 domain containing 7A